FMC Devens - NDC 66215-0602-06
ID: 15B20524Q00000040Type: Combined Synopsis/Solicitation
Overview

Buyer

JUSTICE, DEPARTMENT OFFEDERAL PRISON SYSTEM / BUREAU OF PRISONSFMC DEVENSAYER, MA, 01432, USA

NAICS

Pharmacies and Drug Retailers (456110)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/e9ae730568e4409f960ba91b5c3f4493/view
Timeline
    Description

    The Department of Justice, specifically the Federal Bureau of Prisons at FMC Devens, is seeking quotes for the procurement of specific pharmaceutical products, including Selexipag and Treprostinil, under solicitation number 15B20524Q00000040. The requirement emphasizes the need for brand name medications, with detailed specifications including quantities and National Drug Codes for each item. These cardiovascular agents are critical for the health management of inmates, highlighting the importance of timely and compliant pharmaceutical supply. Interested vendors must submit their quotes by 10:00 a.m. Eastern Standard Time on September 20, 2024, to Charles Coushaine at ccoushaine@bop.gov, ensuring compliance with all applicable federal regulations and contract clauses.

    Point(s) of Contact
    Charles Coushaine
    (978) 796-1136
    ccoushaine@bop.gov
    Eve Rivera-White
    (978) 796-1146
    eriverawhite@bop.gov
    Files
    Title
    Posted
    15B20524Q00000040.pdf
    The document is a solicitation from the Federal Bureau of Prisons (FBOP) for acquiring specific pharmaceutical products as part of a larger procurement effort. The solicitation, identified by the number 15B20524Q00000040, calls for the submission of offers by suppliers to provide various National Drug Codes related to cardiovascular medications, specifically Selexipag and Treprostinil. The deadline for offers is set for September 19, 2024, at 10:00 ET. The evaluation is based on a Lowest Price Technically Acceptable strategy, indicating that the government seeks the most cost-effective solution while meeting technical requirements. The document provides detailed specifications for the supplies, including quantities and pricing structures, along with stipulations for contract compliance, payment methods, and applicable contract clauses derived from the Federal Acquisition Regulation (FAR). Notably, it emphasizes contractors' responsibilities, payment terms, and necessary certifications to protect the interests of the government and ensure compliance with regulatory requirements. Additionally, the solicitation includes various references to federal clauses requiring adherence to procurement standards, small business considerations, and federal compliance procedures, reflecting the government’s commitment to transparency and fairness in contracting.
    Lifecycle
    Title
    Type
    FMC Devens - NDC 66215-0602-06
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Gender Reassignment Services-FMC Fort Worth & FMC Carswell
    Active
    Justice, Department Of
    The Department of Justice, specifically the Federal Bureau of Prisons (FBOP), is soliciting quotes for Gender Reassignment Surgery Services at the Federal Medical Center (FMC) Carswell and FMC Fort Worth in Texas. The procurement aims to provide comprehensive inpatient and outpatient surgical services for federal inmates, including male-to-female and female-to-male transition procedures, post-operative care, and ancillary services such as hair removal. This contract will be structured as an indefinite delivery/requirements type with a base year and four optional renewal years, emphasizing cost-effective healthcare that meets community standards. Interested contractors must register in the System for Award Management (SAM) and submit required documentation, with inquiries directed to Ben Keim at bkeim@bop.gov or Evan A Corley at ecorley@bop.gov.
    COMPREHENSIVE MEDICAL SERVICES - FDC SEATAC
    Active
    Justice, Department Of
    The Department of Justice, specifically the Federal Bureau of Prisons, is seeking proposals for Comprehensive Medical Services at the Federal Detention Center in SeaTac, Washington. The procurement aims to secure a single award for a range of medical services, including inpatient and outpatient facility and physician services, with an indefinite delivery/requirements contract structure that includes a Base Year and four optional renewal years. This contract is crucial for ensuring the health care needs of detainees are met effectively, with estimated service quantities outlined for both inpatient days and outpatient visits. Interested parties should prepare to submit proposals by the anticipated deadline, monitor the official U.S. Government contract opportunities website for updates, and may contact LaShundra D. Thomas at ldthomas@bop.gov or 202-598-6077 for further inquiries.
    Telmisartan Tablets
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Telmisartan Tablets. Telmisartan Tablets are pharmaceutical preparations used to treat high blood pressure and reduce the risk of heart attack, stroke, and kidney problems in certain patients. The tablets will be available in 20MG, 40MG, and 80MG strengths, packaged in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The contract aims to establish a national supply source to provide Telmisartan Tablets to Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. Interested parties can contact Courtney Hunter-Stangler at (215) 737-6845 or Courtney.Hunter-Stangler@dla.mil for any questions/comments. The solicitation is projected to be issued in August of 2024.
    Repaglinide
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Repaglinide Tablets. The contract will establish a national supply source for the purchase of Repaglinide 0.5MG, 1MG, and 2MG in 100 count bottles. This acquisition will be unrestricted and fully competitive. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The items listed in the schedule will be purchased by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. Interested parties should contact Phyllis Daraio for any questions/comments. The projected solicitation date is September 2020.
    Comprehensive Medical Services - FCC Lompoc
    Active
    Justice, Department Of
    The U.S. Department of Justice, Federal Bureau of Prisons is seeking proposals for comprehensive medical services at the Federal Correctional Complex (FCC) in Lompoc, California. The goal is to contract these services for a base year, with the possibility of four extensions, each under a firm-fixed-price agreement. The scope of work involves managing and staffing the medical care facility to provide a comprehensive range of services, including primary care, specialty services, dental care, and emergency response. The awardee will also be responsible for administrative tasks, record-keeping, and medication management, in addition to coordinating mental health services with other healthcare providers. Successful bidders will need to demonstrate their ability to recruit and retain a qualified medical staff, as detailed in the solicitation. This includes having licensed medical professionals and meeting specified staffing ratios. The contract encompasses several key clauses related to indemnification, insurance, and privacy. The evaluation of proposals will consider the quality of services, staff qualifications, past performance, and price, with the former three being leading factors. To apply, vendors must submit their proposals by the deadline on October 1st, 2024, at 2:00 PM local time. For any clarifications or questions, interested parties can contact LaShundra D. Thomas at ldthomas@bop.gov or via phone at 202-598-6077.
    Comprehensive Medical Services - FCC Pollock
    Active
    Justice, Department Of
    The Department of Justice, specifically the Federal Bureau of Prisons, is seeking market input for Comprehensive Medical Services at the Federal Correctional Complex (FCC) in Pollock, Louisiana. The procurement aims to address the healthcare needs of adult inmates, requiring a range of services including inpatient and outpatient facility services, as well as physician services across various specialties. This initiative underscores the Bureau's commitment to providing adequate healthcare for inmate populations while adhering to government procurement practices. Interested parties must respond to the Sources Sought Questionnaire by September 27, 2024, and direct inquiries to LaShundra D. Thomas at ldthomas@bop.gov. All contractors must be registered in the System for Award Management (SAM) database to participate.
    Famotidine
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Famotidine, a drug used to treat ulcers and gastroesophageal reflux disease (GERD). The contract will include Famotidine 20 MG tablets in various bottle sizes and Famotidine 40 MG tablets in different bottle sizes. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The contract aims to establish a national supply source to provide the items for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The annual usage estimates will be provided in the solicitation. The solicitation is expected to be posted on the DLA Bid Board System (DIBBS) and SAM.gov. For any questions or comments, interested parties should contact Kristen Baraniewicz. The projected solicitation date is August 2022, but DLA reserves the right to issue the solicitation before or after that date.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the preparation and distribution of research drug products under a presolicitation notice. The contract will involve acquiring, importing, and exporting drugs and chemical compounds, as well as developing and analyzing various drug dosage forms, including marijuana and nicotine research cigarettes, to support drug abuse and addiction research. This contract is critical for maintaining a reliable supply of authentic controlled and uncontrolled drug compounds for the research community, with an anticipated award of one indefinite delivery, indefinite quantity (IDIQ) contract over a five-year period. Interested parties must possess a current DEA registration and comply with FDA’s current Good Manufacturing Practices, with proposals due approximately 45 days after the release of the RFP, expected on or about September 20, 2024. For further inquiries, contact Scott Duernberger at scott.duernberger@nih.gov or 301-594-0670.
    Comprehensive Medical Services - FCI Atlanta
    Active
    Justice, Department Of
    The Department of Justice, through the Federal Bureau of Prisons, is seeking proposals for Comprehensive Medical Services at the Federal Correctional Institution (FCI) in Atlanta, Georgia. The procurement aims to secure a range of medical services, including inpatient and outpatient care, under a requirements-type contract with a base year and four optional renewal years. This initiative is crucial for ensuring the provision of quality healthcare to incarcerated individuals while adhering to regulatory standards and cost control measures. Proposals are due by October 14, 2024, and interested parties should direct inquiries to Evan A Corley at ecorley@bop.gov or call 202-913-1602. All contractors must be registered in the System for Award Management (SAM) database to participate.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used for treating high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties can contact Catherine Gilbert for more information. The solicitation is projected to be issued in December 2019.